Influence of the confounding factors age and sex on microRNA profiles from peripheral blood

Clinical Chemistry

Volumn 60, Issue 9, 2014, Pages 1200-1208

  Meder, Benjamin ^a,b,c   Backes, Christina ^d   Haas, Jan ^a,b   Leidinger, Petra ^d   Stähler, Cord ^e   Großmann, Thomas ^f   Vogel, Britta ^a   Frese, Karen ^a   Giannitsis, Evangelos ^a   Katus, Hugo A ^a,b,c   Meese, Eckart ^d   Keller, Andreas ^f  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^c Klaus Tschira Institute for Integrative Computational Cardiology   (Germany)

^d SAARLAND UNIVERSITY   (Germany)

^e SIEMENS AG   (Germany)

^f SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MICROARRAY ANALYSIS; MICRORNAS; MIDDLE AGED; REFERENCE STANDARDS; SEX FACTORS; TRANSCRIPTOME;

EID: 84906828527     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2014.224238     Document Type: Article

References (18)

1. Keller A, Leidinger P, Bauer A, Elsharawy A, Haas J, Backes C, et al. Toward the blood-borne miRNome of human diseases. Nat Methods 2011; 8:841-3.
2. Keller A, Leidinger P, Lange J, Borries A, Schroers H, Scheffler M, et al. Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PLoS One 2009;4:e7440.
3. Keller A, Leidinger P, Steinmeyer F, Stahler C, Franke A, Hemmrich-Stanisak G, et al. Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing. Mult Scler 2013.
4. Leidinger P, Backes C, Deutscher S, Schmitt K, Mueller SC, Frese K, et al. A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol 2013;14:R78.
5. Leidinger P, Keller A, Borries A, Huwer H, Rohling M, Huebers J, et al. Specific peripheral miRNA profiles for distinguishing lung cancer from COPD. Lung Cancer 2011;74:41-7.
6. Leidinger P, Keller A, Borries A, Reichrath J, Rass K, Jager SU, et al. High-throughput miRNA profiling of human melanoma blood samples. BMC Cancer 2010;10:262.
7. Meder B, Keller A, Vogel B, Haas J, Sedaghat-Hamedani F, Kayvanpour E, et al. MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction. Basic Res Cardiol 2011;106:13-23.
8. Vogel B, Keller A, Frese KS, Leidinger P, Sedaghat-Hamedani F, Kayvanpour E, et al. Multivariate miRNA signatures as biomarkers for non-ischaemic systolic heart failure. Eur Heart J 2013;34:2812-23.
9. Fenoglio C, Ridolfi E, Cantoni C, De Riz M, Bonsi R, Serpente M, et al. Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis. Mult Scler 2013;19:1938-42.
10. Sayed AS, Xia K, Yang TL, Peng J. Circulating microRNAs: a potential role in diagnosis and prognosis of acute myocardial infarction. Dis Markers 2013;35:561-6.
11. Kiko T, Nakagawa K, Tsuduki T, Furukawa K, Arai H, Miyazawa T. MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer's disease. J Alzheimers Dis 2014;39:253-9.
12. Boon RA, Iekushi K, Lechner S, Seeger T, Fischer A, Heydt S, et al. MicroRNA-34a regulates cardiac ageing and function. Nature 2013;495:107-10.
13. Griffiths-Jones S. The microRNA registry. Nucleic Acids Res 2004;32:D109-11. (Pubitemid 38081615)
14. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. Mirbase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006;34:D140-4.
15. Boeckel JN, Thome CE, Leistner D, Zeiher AM, Fichtlscherer S, Dimmeler S. Heparin selectively affects the quantification of microRNAs in human blood samples. Clin Chem 2013;59:1125-7.
16. Maillot G, Lacroix-Triki M, Pierredon S, Gratadou L, Schmidt S, Benes V, et al. Widespread estrogen-dependent repression of microRNAs involved in breast tumor cell growth. Cancer Res 2009;69:8332-40.
17. Git A, Dvinge H, Salmon-Divon M, Osborne M, Kutter C, Hadfield J, et al. Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression. RNA 2010;16:991-1006.
18. Li X, Khanna A, Li N, Wang E. Circulatory miR34a as an RNAbased, noninvasive biomarker for brain aging. Aging 2011;3:985-1002.